Status:
UNKNOWN
Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies
Lead Sponsor:
Ministry of Science and Technology of the People´s Republic of China
Collaborating Sponsors:
Peking University Third Hospital
Chongqing Medical Center for Women and Children
Conditions:
Twin Pregnancy
Preeclampsia
Eligibility:
FEMALE
18-55 years
Phase:
PHASE4
Brief Summary
Twin pregnancies are associated with increased risk of perinatal adverse outcomes , including preeclampsia , fetal growth restriction , preterm premature rupture of membranes and preterm birth. Low-do...
Eligibility Criteria
Inclusion
- Twin pregnancy diagnosed by ultrasound and maternal age ranged from 18 to 55 years, Gestational age was less than 16w
Exclusion
- Diagnosed fetal anomalies, history of cervical cerclage, contraindications of aspirin, pre-existing renal or liver diseases or abnormal functions, coagulation disorders, history of PE, preterm birth or FGR, chronic hypertension
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT04051567
Start Date
November 1 2018
End Date
December 1 2020
Last Update
October 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hongbo,Qi
Chongqing, Chongqing Municipality, China, 400000